Logo for Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Investor Relations Material

Latest events

Logo for Catalyst Pharmaceuticals Inc

Q1 2025

Catalyst Pharmaceuticals
Logo for Catalyst Pharmaceuticals

Q1 2025

8 May, 2025
Logo for Catalyst Pharmaceuticals

Q4 2024

27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Catalyst Pharmaceuticals Inc

Access all reports
Catalyst Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare neurological and neuromuscular diseases. The company's portfolio includes treatments designed to address conditions such as Lambert-Eaton Myasthenic Syndrome (LEMS) and other disorders that have limited treatment options. The company is headquartered in Coral Gables, Florida, and its shares are listed on the NASDAQ.